Synthesis of 4‐Anilinoquinazoline‐Derivative Dual Kinase Inhibitors Targeting EGFR and VEGFR‐2

E-ISSN： 1229-5949|39|1|123-125

ISSN： 1229-5949

Source： BULLETIN OF THE KOREAN CHEMICAL SOCIETY (ELECTRONIC), Vol.39, Iss.1, 2018-01, pp. : 123-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti‐angiogenic activity of thienopyridine derivative LCB03‐0110 by targeting VEGFR‐2 and JAK/STAT3 Signalling

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 7, 2015-07 ,pp. : 503-509

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of receptor tyrosine kinase inhibitors on VEGF165a‐ and VEGF165b‐stimulated gene transcription in HEK‐293 cells expressing human VEGFR2

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 12, 2015-06 ,pp. : 3141-3150

John Wiley & Sons Inc

Access to resources Recommend Favorite

HGF-MET in Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 228-233

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Gremlin–VEGFR2 axis – a promising strategy for multiple diseases?

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 4, 2015-08 ,pp. : 403-406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer

Oncology, Vol. 86, Iss. 2, 2014-01 ,pp. : 86-93

Karger

Access to resources Recommend Favorite